The Philippine Bureau of Internal Revenue’s RMC 108-2025, issued on 8 January 2026, expands the list of VAT‑exempt drugs under the TRAIN and CREATE Acts. The new list now covers 675 cancer drugs, 542 hypertension drugs, 323 diabetes drugs, 300 mental‑illness drugs, 173 high‑cholesterol drugs, 154 kidney‑disease drugs and 75 tuberculosis drugs, significantly broadening patient access to essential medicines.